Risk factors for anal human papillomavirus infection type 16 among HIV-positive men who have sex with men in San Francisco

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 4, 2013, Pages 532-539

  Hernandez, Alexandra L ^a,b   Efird, Jimmy T ^c   Holly, Elizabeth A ^a   Berry, J Michael ^a   Jay, Naomi ^a   Palefsky, Joel M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Anal cancer; HIV AIDS; HPV; Human papillomavirus; Men who have sex with men; MSM

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; CROSS-SECTIONAL STUDY; DRUG USE; EDUCATIONAL STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16 INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCTION; SEX DIFFERENCE; SEXUAL BEHAVIOR; SMEAR; UNITED STATES;

ADULT; ANAL CANAL; ANTI-RETROVIRAL AGENTS; COINFECTION; CROSS-SECTIONAL STUDIES; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SAN FRANCISCO; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84880216811     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182968f87     Document Type: Article

References (47)

1. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 1987; 317:973-977.
2. Silverberg MJ, Lau B, Justice AC, et al. Risk of anal cancer in HIVinfected and HIV-uninfected individuals in North America. Clin Infect Dis. 2012;54:1026-1034.
3. Bower M, Palmieri C, Dhillon T. AIDS-related malignancies:changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis. 2006;19:14-19.
4. Bower M, Powles T, Newsom-Davis T, et al. HIV-associated anal cancer:has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr. 2004;37:1563-1565.
5. Chiao EY, Krown SE, Stier EA, et al. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr. 2005;40:451-455.
6. Palefsky JM, Holly EA, Ralston ML, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr. 2001;28:422-428.
7. Hessol NA, Pipkin S, Schwarcz S, et al. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol. 2007;165:1143-1153.
8. Melbye M, Palefsky J, Gonzales J, et al. Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities. Int J Cancer. 1990;46:203-206.
9. Caussy D, Goedert JJ, Palefsky J, et al. Interaction of human immunodeficiency and papilloma viruses:association with anal epithelial abnormality in homosexual men. Int J Cancer. 1990;46:214-219.
10. Critchlow CW, Holmes KK, Wood R, et al. Association of human immunodeficiency virus and anal human papillomavirus infection among homosexual men. Arch Intern Med. 1992;152:1673-1676.
11. Kiviat NB, Critchlow CW, Holmes KK, et al. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS. 1993;7:43-49.
12. Palefsky JM, Shiboski S, Moss A. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIVnegative homosexual men. J Acquir Immune Defic Syndr. 1994;7:599-606.
13. Palefsky JM, Holly EA, Ralston ML, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men:prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:320-326.
14. Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111:278-285.
15. Administration FDA. FDA:gardasil approved to prevent anal cancer. 2010. FDA Press release.
16. Critchlow CW, Hawes SE, Kuypers JM, et al. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS. 1998; 12:1177-1184.
17. Kiviat N, Rompalo A, Bowden R, et al. Anal human papillomavirus infection among human immunodeficiency virus-eropositive and -eronegative men. J Infect Dis. 1990;162:358-361.
18. Palefsky JM, Holly EA, Hogeboom CJ, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:314-319.
19. Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 1998;177:361-367.
20. Palefsky JM, Holly EA, Ralston ML, et al. High incidence of anal highgrade squamous intra-epithelial lesions among HIV-positive and HIVnegative homosexual and bisexual men. AIDS. 1998;12:495-503.
21. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med. 2003;138:453-459.
22. Dunne EF, Nielson CM, Stone KM, et al. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis. 2006;194:1044-1057.
23. van der Snoek EM, Niesters HG, Mulder PG, et al. Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis. 2003;30:639-644.
24. Chin-Hong PV, Berry JM, Cheng SC, et al. Comparison of patientand clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med. 2008;149:300-306.
25. Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-pecific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men:The EXPLORE study. J Infect Dis. 2004;190:2070-2076.
26. de Pokomandy A, Rouleau D, Ghattas G, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men:The HIPVIRG cohort study. J Infect Dis. 2009;199:965-973.
27. Vajdic CM, van Leeuwen MT, Jin F, et al. Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. Sex Transm Infect. 2009;85:330-335.
28. Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-analysis. Lancet Oncol. 2012;13:487-500.
29. zur Hausen H. Papillomaviruses in the causation of human cancers- A brief historical account. Virology. 2009;384:260-265.
30. Castellsague X, Ghaffari A, Daniel RW, et al. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: A study in Spain and Colombia. J Infect Dis. 1997; 176:353-361.
31. Lajous M, Mueller N, Cruz-Valdez A, et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev. 2005;14:1710-1716.
32. Kjaer SK, Munk C, Winther JF, et al. Acquisition and persistence of human papillomavirus infection in younger men: A prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev. 2005; 14:1528-1533.
33. Franceschi S, Castellsague X, Dal Maso L, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer. 2002;86:705-711.
34. Svare EI, Kjaer SK, Worm AM, et al. Risk factors for genital HPV DNA in men resemble those found in women: A study of male attendees at a Danish STD clinic. Sex Transm Infect. 2002;78:215-218.
35. Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-related prevalence of anal cancer precursors in homosexual men:The EXPLORE study. J Natl Cancer Inst. 2005;97:896-905.
36. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527.
37. Blizzard L, Hosmer DW. Parameter estimation and goodness-of-fit in log binomial regression. Biom J. 2006;48:5-22.
38. Damay A, Fabre J, Costes V, et al. Human papillomavirus (HPV) prevalence and type distribution, and HPV-associated cytological abnormalities in anal specimens from men infected with HIV who have sex with men. J Med Virol. 2010;82:592-596.
39. Palefsky J. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS. 2009;4:52-56.
40. IARC. Human papillomavirus. IARC Monogr Eval Carcinogenic Risks Humans. 2007;90.
41. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92:1500-1510.
42. Benard VB, Johnson CJ, Thompson TD, et al. Examining the association between socioeconomic status and potential human papillomavirusassociated cancers. Cancer. 2008;113:2910-2918.
43. Karlamangla AS, Merkin SS, Crimmins EM, et al. Socioeconomic and ethnic disparities in cardiovascular risk in the United States, 2001-2006. Ann Epidemiol. 2010;20:617-628.
44. Kondo N. Socioeconomic disparities and health:impacts and pathways. J Epidemiol. 2012;22:2-6.
45. Vona-Davis L, Rose DP. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: A review. J Womens Health (Larchmt). 2009;18:883-893.
46. Celentano DD, Latimore AD, Mehta SH. Variations in sexual risks in drug users:emerging themes in a behavioral context. Curr HIV/AIDS Rep. 2008;5:212-218.
47. Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr. 1998;23:15-20.